Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin

Fricke, J; Kargbo, R; Regestein, L; Lenz, C; Peschel, G; Rosenbaum, MA; Sherwood, A; Hoffmeister, D

Hoffmeister, D (corresponding author), Friedrich Schiller Univ, Dept Pharmaceut Microbiol, Hans Knoll Inst, Beutenbergstr 11a, D-07745 Jena, Germany.

CHEMISTRY-A EUROPEAN JOURNAL, 2020; 26 (37): 8281

Abstract

Psilocybin, the principal indole alkaloid of Psilocybe mushrooms, is currently undergoing clinical trials as a medication against treatment-resistant ......

Full Text Link